BTSG Relative Valuation
BTSG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BTSG is overvalued; if below, it's undervalued.
Historical Valuation
Brightspring Health Services Inc (BTSG) is now in the Undervalued zone, suggesting that its current forward PE ratio of 28.38 is considered Undervalued compared with the five-year average of 23.26. The fair price of Brightspring Health Services Inc (BTSG) is between 70.36 to 82.62 according to relative valuation methord. Compared to the current price of 35.16 USD , Brightspring Health Services Inc is Undervalued By 50.03%.
Relative Value
Fair Zone
70.36-82.62
Current Price：35.16
50.03%
Undervalued
28.38
PE
1Y
3Y
5Y
Trailing
Forward
14.58
EV/EBITDA
Brightspring Health Services Inc. (BTSG) has a current EV/EBITDA of 14.58. The 5-year average EV/EBITDA is 10.33. The thresholds are as follows: Strongly Undervalued below 6.96, Undervalued between 6.96 and 8.65, Fairly Valued between 12.01 and 8.65, Overvalued between 12.01 and 13.69, and Strongly Overvalued above 13.69. The current Forward EV/EBITDA of 14.58 falls within the Strongly Overvalued range.
22.19
EV/EBIT
Brightspring Health Services Inc. (BTSG) has a current EV/EBIT of 22.19. The 5-year average EV/EBIT is 16.93. The thresholds are as follows: Strongly Undervalued below 11.94, Undervalued between 11.94 and 14.44, Fairly Valued between 19.43 and 14.44, Overvalued between 19.43 and 21.93, and Strongly Overvalued above 21.93. The current Forward EV/EBIT of 22.19 falls within the Strongly Overvalued range.
0.52
PS
Brightspring Health Services Inc. (BTSG) has a current PS of 0.52. The 5-year average PS is 0.27. The thresholds are as follows: Strongly Undervalued below 0.07, Undervalued between 0.07 and 0.17, Fairly Valued between 0.37 and 0.17, Overvalued between 0.37 and 0.46, and Strongly Overvalued above 0.46. The current Forward PS of 0.52 falls within the Strongly Overvalued range.
17.49
P/OCF
Brightspring Health Services Inc. (BTSG) has a current P/OCF of 17.49. The 5-year average P/OCF is 10.28. The thresholds are as follows: Strongly Undervalued below 4.31, Undervalued between 4.31 and 7.29, Fairly Valued between 13.26 and 7.29, Overvalued between 13.26 and 16.24, and Strongly Overvalued above 16.24. The current Forward P/OCF of 17.49 falls within the Strongly Overvalued range.
22.06
P/FCF
Brightspring Health Services Inc. (BTSG) has a current P/FCF of 22.06. The 5-year average P/FCF is 15.08. The thresholds are as follows: Strongly Undervalued below 6.17, Undervalued between 6.17 and 10.63, Fairly Valued between 19.53 and 10.63, Overvalued between 19.53 and 23.98, and Strongly Overvalued above 23.98. The current Forward P/FCF of 22.06 falls within the Overvalued range.
Brightspring Health Services Inc (BTSG) has a current Price-to-Book (P/B) ratio of 4.00. Compared to its 3-year average P/B ratio of 2.08 , the current P/B ratio is approximately 92.70% higher. Relative to its 5-year average P/B ratio of 2.08, the current P/B ratio is about 92.70% higher. Brightspring Health Services Inc (BTSG) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 2.22%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.22% , the current FCF yield is about -100.00% lower.
4.00
P/B
Median3y
2.08
Median5y
2.08
3.79
FCF Yield
Median3y
2.22
Median5y
2.22
Competitors Valuation Multiple
The average P/S ratio for BTSG's competitors is , providing a benchmark for relative valuation. Brightspring Health Services Inc Corp (BTSG) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 28.17%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BTSG increased by 106.46% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 17.48 to 68.43.
The secondary factor is the Revenue Growth, contributed 28.17%to the performance.
Overall, the performance of BTSG in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Brightspring Health Services Inc (BTSG) currently overvalued or undervalued?
What is Brightspring Health Services Inc (BTSG) fair value?
How does BTSG's valuation metrics compare to the industry average?
What is the current P/B ratio for Brightspring Health Services Inc (BTSG) as of Dec 05 2025?
What is the current FCF Yield for Brightspring Health Services Inc (BTSG) as of Dec 05 2025?
What is the current Forward P/E ratio for Brightspring Health Services Inc (BTSG) as of Dec 05 2025?